Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» liver disease
liver disease
Intercept Pharma rises as analyst raises her price and sales estimates for its liver drug OCA
Yahoo/AP
Mon, 02/10/14 - 05:29 pm
OCA
liver disease
Intercept Pharma
Liver Drug Race: Intercept Pharma Vs. Rivals
Seeking Alpha
Mon, 01/27/14 - 08:21 am
Intercept Pharma
liver disease
OCA
Conatus Pharmaceuticals
Gilead Sciences
Galectin
NASH
non-alcoholic fatty liver disease
Intercept CEO says new drug could treat ‘next tsunami’ in liver disease
Marketwatch
Wed, 01/15/14 - 05:21 pm
Intercept Pharma
liver disease
nonalcoholic steatohepatitis
OCA
Intercept stock triples on liver disease study
Yahoo/AP
Fri, 01/10/14 - 08:20 am
Intercept Pharma
liver disease
obeticholic acid
Intercept shares dazzle after early success of PhIIb liver disease drug trial
Fierce Biotech
Thu, 01/9/14 - 09:35 am
Intercept Pharma
liver disease
Does Conatus Pharmaceuticals Have A Winner With Emricasan?
Seeking Alpha
Thu, 09/26/13 - 08:12 am
Conatus Pharmaceuticals
emricasan
Gilead
Merck
Pfizer
liver disease
Sunesis
apoptosis
Data on Cempra's Solithromycin
Yahoo/Zacks
Sat, 09/7/13 - 11:42 am
Cempra
Solithromycin
liver disease
Study of Glaxo platelet drug halted due to clots
Reuters
Thu, 05/13/10 - 09:10 am
GSK
clinical trials
liver disease
Promacta
Raptor's liver disease drug meets mid-stage trial goal
Reuters
Mon, 05/3/10 - 01:09 pm
Raptor Pharmaceuticals
liver disease
Pages
« first
‹ previous
1
2
3
4